​

Vanda Pharmaceuticals Ownership | Who Owns Vanda Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Vanda Pharmaceuticals Ownership Summary

Vanda Pharmaceuticals is owned by 11.55% institutional investors, 7.21% insiders, and 81.25% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.12% of VNDA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.99% of its assets in Vanda Pharmaceuticals shares.

VNDA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVanda Pharmaceuticals11.55%7.21%81.25%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de8.92M15.12%$44.50M
Blackrock8.14M14.09%$45.98M
Vanguard group3.59M6.08%$17.90M
Renaissance3.48M5.89%$17.35M
Dimensional fund advisors lp2.56M4.35%$12.79M
Tang capital management2.35M3.99%$11.74M
Acadian asset management2.23M3.78%$11.12M
Millennium management2.14M3.66%$9.82M
Jacobs levy equity management1.49M2.57%$8.40M
Geode capital management1.39M2.36%$6.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management1.18M2.51%$5.89M
Profit investment management186.40K1.17%$930.13K
Empire financial management company758.09K0.87%$3.78M
Stonepine capital management195.00K0.79%$973.05K
Tang capital management2.35M0.45%$11.74M
Pharvision advisers57.04K0.16%$284.62K
Gsa capital partners llp318.80K0.13%$1.59M
Monaco asset management sam247.81K0.08%$1.24M
One68 global capital26.06K0.06%$119.61K
Jacobs levy equity management1.49M0.03%$8.40M

Top Buyers

HolderShares% AssetsChange
Millennium management2.14M0.01%1.47M
Empire financial management company758.09K0.87%563.09K
Acadian asset management2.23M0.02%496.85K
Qube research179.25K0.00%179.25K
Krensavage asset management1.18M2.51%155.50K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---1.59M
Bank of america corp /de/77.42K--1.13M
Citigroup26.61K0.00%-854.00K
Assenagon asset management---730.82K
Blackrock funding, inc. /de8.92M0.00%-517.32K

New Positions

HolderShares% AssetsChangeValue
Jump financial138.00K0.01%138.00K$688.62K
Panagora asset management115.06K0.00%115.06K$574.14K
Norges bank115.00K0.00%115.00K$550.85K
Cubist systematic strategies63.82K0.00%63.82K$318.47K
Pharvision advisers57.04K0.16%57.04K$284.62K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Nelson, van denburg & campbell wealth management group-10.00
Ifp advisors-10.00
Gps wealth strategies group-25.00
Assetmark-31.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202551-64.34%6,811,734-84.86%110.20%22-67.65%15-67.39%
Jun 30, 2025142-7.79%44,993,3852.43%761.35%673.08%46-16.36%
Mar 31, 20254-97.33%2,360,082-94.49%40.07%3-95.95%--100.00%
Dec 31, 2024140-11.39%41,400,330-5.62%711.25%71-2.74%39-23.53%
Sep 30, 20241581.94%43,866,8090.75%751.32%73-14.12%5110.87%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.74M2.99%-
Vanguard Total Stock Mkt Idx Inv1.71M2.89%-37.60K
iShares Russell 2000 ETF1.33M2.25%-
BlackRock Advantage Small Cap Core Instl1.03M1.75%-3.65K
Federated Hermes MDT Small Cap Core IS624.55K1.06%-
Federated Hermes MDT SCC Institutional624.55K1.06%-
Vanguard Institutional Extnd Mkt Idx Tr616.09K1.04%-280.74K
Fidelity Small Cap Index554.70K0.94%-20.39K
Nuveen Quant Small Cap Equity R6530.50K0.91%166.10K
iShares Russell 2000 Value ETF479.56K0.81%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 07, 2025Polymeropoulos Mihael Hristos President and CEOBuy$41.50K
Jun 13, 2025Mitchell Stephen Ray-Sell$32.13K
May 21, 2025Polymeropoulos Mihael Hristos President and CEOBuy$2.11K
May 21, 2025Polymeropoulos Mihael Hristos President and CEOBuy$41.88K
May 16, 2025Polymeropoulos Mihael Hristos President and CEOBuy$84.47K

Insider Transactions Trends

DateBuySell
2025 Q31-
2025 Q231
2025 Q111-
2024 Q4-1
2024 Q3-1

VNDA Ownership FAQ

Who Owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals shareholders are primarily institutional investors at 11.55%, followed by 7.21% insiders and 81.24% retail investors. The average institutional ownership in Vanda Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Vanda Pharmaceuticals falls below.

Who owns the most shares of Vanda Pharmaceuticals?

Vanda Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (8.92M shares, 15.12%), Blackrock (8.14M shares, 14.09%), and Vanguard group (3.59M shares, 6.08%). Together, they hold 35.29% of Vanda Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vanda Pharmaceuticals?

Yes, BlackRock owns 14.09% of Vanda Pharmaceuticals, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 45.98M$. In the last quarter, BlackRock decreased its holdings by -1.629K shares, a -0.02% change.

Who is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.51% of its assets in 1.18M Vanda Pharmaceuticals shares, valued at 5.89M$.

Who is the top mutual fund holder of Vanda Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Vanda Pharmaceuticals shares, with 2.99% of its total shares outstanding invested in 1.74M Vanda Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools